Mayflower Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $514K | Buy |
7,454
+2,380
| +47% | +$164K | 0.07% | 238 |
|
|
2025
Q1 | $352K | Sell |
5,074
-2,539
| -33% | -$176K | 0.05% | 276 |
|
|
2024
Q4 | $655K | Buy |
7,613
+894
| +13% | +$76.9K | 0.1% | 188 |
|
|
2024
Q3 | $800K | Buy |
6,719
+88
| +1% | +$10.5K | 0.12% | 161 |
|
|
2024
Q2 | $946K | Buy |
6,631
+2,436
| +58% | +$348K | 0.16% | 135 |
|
|
2024
Q1 | $539K | Buy |
4,195
+1,899
| +83% | +$244K | 0.09% | 198 |
|
|
2023
Q4 | $238K | Buy |
2,296
+70
| +3% | +$7.24K | 0.03% | 301 |
|
|
2023
Q3 | $202K | Buy |
+2,226
| New | +$202K | 0.03% | 319 |
|